http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0226271-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71c973d3447f2ef5c41cdbe910a41783 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-90 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-90 |
| filingDate | 1986-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_571df2c8a1ca49dc6f1719bf1370d34b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78f0e28802af69bd4ff480b23f8cbd1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79e8de71de2e5b6277e4ded076aaeb88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e785895386f921ef19a05761b9e8b83b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cde289fec0e5d94fca0fb400c92ef2e3 |
| publicationDate | 1987-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0226271-A1 |
| titleOfInvention | 1,4-Dihydropyridine compounds and their preparation and pharmaceutical formulation |
| abstract | 1,4-Dinydropyridine compounds and men pr Compounds are described of the formulan whereinn R, and R 4 independently represent a C 1-4 alkyl group; R 2 and R 3 independently represent a C 1-6 straight or branched alkyl chain or alkoxy group; R s represents a straight or branched chain C 1-13 alkyl group or a C 5-8 cycloalkyl group which may be substituted by a C 1-3 alkyl substituent; R 6 represents a halogen atom or a straight or branched C 1-3 alkyl group. n The compounds represented by formula (I) reduce intracellular calcium ion concentration by limiting transmembranal calcium ion reflux and thus may be useful for the treatment of cardiovascular disorders such as hypertension. |
| priorityDate | 1985-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 277.